Basel Common Stock from 2010 to 2026
| BMGL Stock | 0.63 0.03 4.55% |
Common Stock | First Reported 2010-12-31 | Previous Quarter 39.3 M | Current Value 41.3 M | Quarterly Volatility 15.6 M |
Check Basel Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Basel Medical's main balance sheet or income statement drivers, such as Interest Income of 125.1 K, Depreciation And Amortization of 781.8 K or Interest Expense of 187.9 K, as well as many indicators such as Price To Sales Ratio of 8.98, Dividend Yield of 0.0 or PTB Ratio of 24.43. Basel financial statements analysis is a perfect complement when working with Basel Medical Valuation or Volatility modules.
Basel | Common Stock | Build AI portfolio with Basel Stock |
Latest Basel Medical's Common Stock Growth Pattern
Below is the plot of the Common Stock of Basel Medical Group over the last few years. It is Basel Medical's Common Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Basel Medical's overall financial position and show how it may be relating to other accounts over time.
| Common Stock | 10 Years Trend |
|
Common Stock |
| Timeline |
Basel Common Stock Regression Statistics
| Arithmetic Mean | 8,194,737 | |
| Geometric Mean | 290.50 | |
| Coefficient Of Variation | 190.04 | |
| Mean Deviation | 12,533,115 | |
| Median | 8.00 | |
| Standard Deviation | 15,573,509 | |
| Sample Variance | 242.5T | |
| Range | 41.3M | |
| R-Value | 0.74 | |
| Mean Square Error | 116.4T | |
| R-Squared | 0.55 | |
| Significance | 0.0007 | |
| Slope | 2,287,649 | |
| Total Sum of Squares | 3880.5T |
Basel Common Stock History
Other Fundumenentals of Basel Medical Group
Basel Medical Common Stock component correlations
Click cells to compare fundamentals
About Basel Medical Financial Statements
Basel Medical investors utilize fundamental indicators, such as Common Stock, to predict how Basel Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 21.6 M | 20.6 M | |
| Common Stock | 39.3 M | 41.3 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Basel Medical Correlation against competitors. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Basel Medical. If investors know Basel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Basel Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.50) | Revenue Per Share | Quarterly Revenue Growth 0.322 | Return On Assets | Return On Equity |
The market value of Basel Medical Group is measured differently than its book value, which is the value of Basel that is recorded on the company's balance sheet. Investors also form their own opinion of Basel Medical's value that differs from its market value or its book value, called intrinsic value, which is Basel Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Basel Medical's market value can be influenced by many factors that don't directly affect Basel Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Basel Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Basel Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Basel Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.